Christopher Jones † , Victor Snieckus † , Greg Ross ‡
description
Transcript of Christopher Jones † , Victor Snieckus † , Greg Ross ‡
1
First Directed First Directed orthoortho Metalation (DoM) of Metalation (DoM) of
1,8-Naphthalene Diamides.1,8-Naphthalene Diamides.Towards Nerve GrowthTowards Nerve Growth
Factor Inhibitors Factor Inhibitors
Christopher Jones†, Victor Snieckus†, Greg Ross ‡
†Department of Chemistry, Queen’s University, Kingston, ON, CANADA K7L 3N6‡ Department of Physiology, Queen’s University, Kingston, ON, CANADA K7L 3N6
2
Nerve Growth Factor (NGF)Nerve Growth Factor (NGF)
• Involved in the neuronal development in the Central Nervous System and Peripheral Nervous System.
• Nerve Growth Factor is implicated in Alzheimer’s, epilepsy, stroke and pain.
• Production is stimulated in patients suffering from Arthritis pain.
• Inhibition of NGF causes reduction in pain levels.
Ross, G. et al. J. Amer. Chem. Soc, 99 121, 1997
3
Previously Identified NGF InhibitorsPreviously Identified NGF Inhibitors
N
RO
O
N
O
O
R =
O
OH
NCP 205
HN
OHALE 540
N
O
O
Ar
Ar
EWG
Ar =
R1
Target Molecules
Ross, G. et al. J. Amer. Chem. Soc, 99 121, 1997
4
Directed Directed orthoortho Metalation (DoM) Reactions Metalation (DoM) Reactions in Organic Synthesisin Organic Synthesis
DMG
E+
E+N-COR (R = Ot-Bu, t-Bu)
OCONEt2
O
N
Muchowski, Gschwend 1978
Snieckus, 1983
DMG
Meyers, Gschwend, 1975
CONEt2 Beak, 1977
OMOM Christensen, 1975
SO2NR2 Hauser, 1968
P(O)(t-Bu)2 Snieckus, 1998
CON--Cumyl
SO2N--Cumyl
OCON(Me)-Cumyl
Snieckus, 1999
Ph
DMG
Hartung, C, Snieckus, V. Modern Arene Chemistry, Wiley-VCH, Weinheim. 2002, 330
5
Advantages of Directed Advantages of Directed orthoortho Metalation Metalation
Mild Conditions
-78oC 0oC rtTHF or Et2O or DME
Regioselective E+ - Ar SubstComplement
Contiguous SubstitutionPatterns
FG
DMG DMG
DoM
E+
E+
DMG
E1+
E2+
DMG1
DMG2
E+
(m-DMG)
(p-DMG)
Iterative (ring - walk)
DMG1
DMG2
DMG3
(DMG2 > DMG1)
- -
---
--
-Recent Work1. Kalinin,A.; Snieckus, V. et al. J Org Chem, 2003, 68, 59922. Chauder, B.; Snieckus, V. et al. Org Lett, 2002, 4, 815
6
Previous Work Involving 2,7-Disubstituted Previous Work Involving 2,7-Disubstituted 1,8-Naphthalene Systems1,8-Naphthalene Systems
OCONEt2Et2NOCO
PhPh
OMOMMOMO
PhPh
OHOH
PhPh
Ligand for TiCl4
No Cleavageof Carbamate
CH3OH/ 12 N HCl
CH2Cl2
Wuest, J et al Organometallics, 1996,15, 1296
SuzukiCross Couple
7
DoM Chemistry of Naphthalene-DoM Chemistry of Naphthalene-bis-Diethylamides. First Resultsbis-Diethylamides. First Results
Et2NOC CONEt2Et2NOC CONEt2
TMSTMS4.4 secBuLi4.4 TMEDA / THF
-78*C 4.4 / TMSCl
• Amide steric interactions provides high rotational barriers
•Amides are positioned parallel to each other and perpendicular to the aromatic ring.
Jones, C; Snieckus, V.; Ross, G. unpublished results 2003
50%
8
DoM Chemistry of Naphthalene DoM Chemistry of Naphthalene 1,8-bis-Diethylamide Generalization1,8-bis-Diethylamide Generalization
1. secBuLi /TMEDA/ THF
-78*C 2. E+ Quench
Et2NOC CONEt2Et2NOC CONEt2
EE
• Br2 derivative achieved by Ipsodesilaytion reaction on the bis TMS derivative.
E+ Equiv. % Yeild TMSCl 4.4 50 % DMF 2.2 40 % Br2 Excess 78% a
9
Mono or Di Deprotonation of NaphthaleneMono or Di Deprotonation of Naphthalenebis-Diethylamide.bis-Diethylamide. What pathway does the What pathway does the
deprotonation follow??deprotonation follow??
CONEt2Et2NOC
secBuLi / TMEDA
THF
CONEt2Et2NOC
CONEt2Et2NOC CONEt2Et2NOC
H
secBuLi / TMEDATHF
CONEt2Et2NOC
E+ QuenchEE
E+ = TMSCl, B(OR)3, X2, DMF
•Determined by CD3OD Quench Experiments
10
cj069-0
324 325 326 327 328 329 330 331 332 333 334Da/e0
100
%
328.5
327.5
326.5
325.5
329.5
330.4
331.4
cj069-10
325 326 327 328 329 330 331 332 333Da/e0
100
%
328.3
327.3
326.3
329.3
330.4
331.4
cj069-20
325 326 327 328 329 330 331 332 333 334Da/e0
100
%
328.5
327.3
326.3
330.4
329.5
331.4
cj068-30
325 326 327 328 329 330 331 332 333 334Da/e0
100
%
330.4
328.3
327.3
326.3
329.5
331.4
332.4
cj068-1
325 326 327 328 329 330 331 332 333Da/e0
100
%
328.3
327.3
326.3
330.3
329.3
331.3
cj068-6
325 326 327 328 329 330 331 332 333Da/e0
100
%
328.5
327.5
326.5
329.5
330.4
331.4
Mono vs Bis Incorporation of Deuterium Mono vs Bis Incorporation of Deuterium Monitored by EI Monitored by EI+ + MS over TimeMS over Time
cj068 blk
324 325 326 327 328 329 330Da/e0
100
%
326.3
325.4
327.3
328.3
M+ Peak at 326
• M+ Peak increases to 328 after addition of SecBuLi and quench with CD3OD
• Time does not increase or decrease the 328 peak
Time 0 10 Min
20 Min 30 Min
1 Hr 6 Hr
M+ Peak at 328
11
cj067-1.1
324 325 326 327 328 329 330 331Da/e0
100
%
328.3
327.3
326.3
329.3
cj067-2.2
325 326 327 328 329 330 331 332 333Da/e0
100
%
328.3
327.3
326.3
330.4329.3
331.4
cj067-3.3
325 326 327 328 329 330 331 332 333Da/e0
100
%
328.3
327.3
326.3
330.4
329.3
331.4
cj067-4.4
325 326 327 328 329 330 331 332 333Da/e0
100
%
328.3
327.3
326.3
330.3
329.3
331.4
cj068 blk
324 325 326 327 328 329 330Da/e0
100
%
326.3
325.4
327.3
328.3
What Role Does the Equivalents of Base Have What Role Does the Equivalents of Base Have on formation of Mono or Bis?on formation of Mono or Bis?
Starting Material
M+ Peak at 326M+ Peak at 328
1.1 Eqv 2.2 Eqv
3.3 Eqv 4.4 Eqv
• Number equivalents of s-BuLi do not have an effect on the formation of Mono vs Bis Deuterated product.
12
Bromo Ipsodesilaytion of Naphthalene-Bromo Ipsodesilaytion of Naphthalene-1,8-dicarboxylic acid bis-diethylamide1,8-dicarboxylic acid bis-diethylamide
CH2Cl2 / Reflux
Et2NOC CONEt2
TMSTMS
Et2NOC CONEt2
BrBrBr2
Colvin, E.W. Silicon in Organic Synthesis. Butterworth: London, 1988
SiR3
E+
R3Si E
-SiR3+
E
+
A
E+ = Br+, I+, NO2+, PhCO+, MeCO+.
General Ipso-substitution Reaction
•Synthesize unconventional substitution
patterns.
•Alternative short route with improved yield.
•Regioselective,clean reaction with mild
conditions.
78%
13
Met+
DMG B(OR)3 MgX2 ZnX2 ClSnR3
CONEt2 OCONEt2 ?OMOM N-Boc x x ?SO2NEt2 x ? ? ?
RLi
DMG
Met+ DMG
XB(OR)2
Pd0
DDooM-Cross Coupling ConnectionsM-Cross Coupling Connections
14
Suzuki - Miyaura Cross Coupling of 2,7 – diBr Suzuki - Miyaura Cross Coupling of 2,7 – diBr Naphthalene 1,8-Bis-DiethylamideNaphthalene 1,8-Bis-Diethylamide
Et2NOC CONEt2 Et2NOC CONEt2
BrBr
B(OH)2
Catalyst
BaseSolventReflux 72 hours
RRR
B(OH)2
Boronic Acid Base Catalyst Solvent %Yield Na2CO3 Pd(PPh3)4 DME 0 KF Pd(dba)3 [(t-Bu)3PH]BF4 Toluene 0 K3PO4 Pd(PPh3)4 DMF 32%
15
AcknowledgementsAcknowledgements
• Dr. Victor Snieckus• Dr. Greg Ross• Dr. Christian Hartung• Dr. Bert Nolte• Dr. Bernd Keller• The Snieckus Group